66491-80-3Relevant academic research and scientific papers
1-phenyl-4(1H)-quinazolinones and 2,3-dihydro-1-phenyl-4(1H)-quinazolinones as potential cholecystokinin receptor ligands
Pentassuglia, Giorgio,Bertani, Barbara,Donati, Daniele,Ursini, Antonella
, p. 1163 - 1170 (2007/10/03)
A series of new 1-phenyl-4(1H)-quinazolinones and 2,3-dihydro-1-phenyl-4(1H)-quinazolinones were synthesized and tested as cholecystokinin receptor ligands. All the compounds showed moderate affinity and 1-phenyl-4(1H)-quinazolinones resulted more effecti
Studies on 4(1H)-quinazolinones. 5. Synthesis and antiinflammatory activity of 4(1H)-quinazolinone derivatives
Ozaki,Yamada,Oine,Ishizuka,Iwasawa
, p. 568 - 576 (2007/10/02)
A number of new 4(1H)-quinazolinones were synthesized and evaluated in the carrageenin-induced paw edema test. Most of the compounds were obtained by the cyclization of the appropriately substituted anthranilamides with acid chlorides, followed by further chemical transformation. Structure-activity data suggest that 2-isopropyl-1-phenyl-, 2-cyclopropyl-1-phenyl-, and 1-isopropyl-2-phenyl-4(1H)-quinazolinones afford optimal potency and the presence of a halogen atom is preferred for activity. Adrenalectomy does not affect the antiinflammatory test results. The best result taking into account both efficacy and side effects was displayed by 1-isoproyl-(2-fluorophenyl)-4(1H)-quinazolinone.
